ADRB2 rs1042717: Understanding This Genetic Variant
The rs1042717 variant is a synonymous single nucleotide polymorphism located within the ADRB2 gene, which encodes the beta-2 adrenergic receptor. While it is frequently discussed in research regarding endurance sports traits and receptor regulation, current evidence linking this specific variant to athletic performance remains limited and inconclusive.
What each genotype means
Associated with clinical outcomes
Research has observed that individuals with this genotype may experience different outcomes in specific critical care settings, such as septic shock, where it has been linked to higher rates of organ dysfunction and mortality in some studies. This variant is synonymous, meaning it does not change the amino acid sequence of the protein, so these associations are likely due to linkage with other functional genetic markers. Please discuss any concerns regarding clinical management or treatment responses with your healthcare provider.
This genotype is found in a significant portion of the global population, though exact frequencies vary by ancestry.
Common genetic variation
This genotype represents a heterozygous state for this synonymous variant in the ADRB2 gene. While the variant itself does not alter the protein structure, it is often studied alongside other genetic markers to understand individual differences in physiological responses. Current evidence regarding its specific impact on health or athletic performance remains limited and inconclusive.
This is a common genotype observed across diverse global populations.
Common genetic variation
This genotype represents the alternative homozygous state for this synonymous variant. As a synonymous change, it does not directly modify the beta-2 adrenergic receptor protein, and its role in modulating receptor function or endurance traits is not well-established. Research into this variant is ongoing, and it is not currently used to guide clinical decision-making.
This genotype is widely distributed and common across most human populations.
What is rs1042717?
The rs1042717 variant is a specific change in the DNA sequence of the ADRB2 gene. In genetics, a 'synonymous' polymorphism means that while the DNA letter changes, the resulting protein sequence remains the same. This variant is located on chromosome 5 and is one of many variations found within the ADRB2 gene. Because it does not alter the amino acid sequence of the protein, researchers often investigate whether it might influence how the gene is expressed or how the messenger RNA is processed, though the functional impact of this specific change is not fully understood.
The Role of the ADRB2 Gene
The ADRB2 gene provides instructions for making the beta-2 adrenergic receptor. This receptor is found on the surface of many cell types throughout the body, including those in the heart, lungs, and skeletal muscle. It acts as a sensor for catecholamines, such as adrenaline, which are hormones that help the body respond to stress and physical exertion. By binding to these hormones, the receptor helps regulate critical physiological processes, including heart rate, the relaxation of smooth muscles in the airways, and the mobilization of energy stores like fat and glucose during exercise.
Research and Athletic Performance
Because the ADRB2 receptor is involved in energy metabolism and muscle function, scientists have long hypothesized that variations in this gene might influence athletic performance. Some studies have explored whether specific ADRB2 genotypes are more common in elite endurance athletes compared to the general population. However, large-scale studies, such as the GENATHLETE study, have generally failed to find strong, consistent evidence that any single ADRB2 variant, including rs1042717, acts as a major determinant of athletic success. The current scientific consensus suggests that athletic ability is a complex trait influenced by thousands of genetic variants and environmental factors, rather than a single SNP.
Interpreting Your Genetic Information
It is important to approach genetic information about variants like rs1042717 with caution. Because the evidence linking this variant to specific physical traits is limited and often conflicting, it cannot be used to predict athletic potential or health outcomes. Genetic testing for such variants is not a substitute for professional training, medical advice, or clinical assessment. If you have questions about how your genetics might relate to your health or physical performance, consult with a qualified healthcare provider or a genetic counselor who can help you interpret these findings within the context of your overall health history.
How common is this variant?
The rs1042717 variant is common globally, with a minor allele frequency of approximately 0.40, meaning the different genotypes are widely distributed across various ancestral populations.
Frequently asked questions
Is rs1042717 a predictor of athletic ability?
No. Current scientific research has not established a strong link between this variant and athletic performance. Athletic ability is influenced by a vast combination of genetic and environmental factors.
Does this variant affect how I respond to asthma medication?
While some ADRB2 variants are studied in the context of pharmacogenomics, rs1042717 is not a primary marker for medication response. Always discuss your medication dosing and treatment plans with your doctor or pharmacist.
Should I change my training based on my rs1042717 genotype?
No. There is no evidence-based guidance that suggests training regimens should be altered based on this specific genetic variant. Focus on evidence-based training principles and consult with a professional coach or trainer.
Is this variant considered a disease-causing mutation?
No. rs1042717 is a common polymorphism, which is a normal variation in the human genome. It is not classified as a disease-causing mutation.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042717?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB2
Variant in the beta-2 adrenergic receptor linked to metabolic regulation, exercise-induced lipolysis, and endurance performance.
The Gln27Glu variant in the beta-2 adrenergic receptor is associated with metabolic and vascular responses to exercise.
Modulates beta-2 adrenergic receptor expression and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with differential responses to beta-agonist therapy in asthma patients.
Functional variant in the beta-2 adrenergic receptor linked to metabolic rate and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with altered responses to asthma medications and bronchodilators.